Department of Pediatrics, Vanderbilt University, Nashville, TN 37232, USA.
Am J Respir Crit Care Med. 2012 Mar 1;185(5):508-16. doi: 10.1164/rccm.201108-1462OC. Epub 2011 Dec 1.
Human rhinoviruses (HRV) are the leading cause of upper respiratory infections and have been postulated to trigger asthma exacerbations. However, whether HRV are detected during crises because upper respiratory infections often accompany asthma attacks, or because they specifically elicit exacerbations, is unclear. Moreover, although several hypotheses have been advanced to explain virus-induced exacerbations, their mechanism remains unclear.
To determine the role of HRV in pediatric asthma exacerbations and the mechanisms mediating wheezing.
We prospectively studied 409 children with asthma presenting with upper respiratory infection in the presence or absence of wheezing. Candidate viral and immune mediators of illness were compared among children with asthma with different degrees of severity of acute asthma.
HRV infections specifically associated with asthma exacerbations, even after adjusting for relevant demographic and clinical variables defined a priori (odds ratio, 1.90; 95% confidence interval, 1.21-2.99; P = 0.005). No difference in virus titers, HRV species, and inflammatory or allergic molecules was observed between wheezing and nonwheezing children infected with HRV. Type III IFN-λ(1) levels were higher in wheezing children infected with HRV compared with nonwheezing (P < 0.001) and increased with worsening symptoms (P < 0.001). Moreover, after adjusting for IFN-λ(1), children with asthma infected with HRV were no longer more likely to wheeze than those who were HRV-negative (odds ratio, 1.18; 95% confidence interval, 0.57-2.46; P = 0.66).
Our findings suggest that HRV infections in children with asthma are specifically associated with acute wheezing, and that type III IFN-λ(1) responses mediate exacerbations caused by HRV. Modulation of IFN- λ(1) should be studied as a therapeutic target for exacerbations caused by HRV.
人类鼻病毒(HRV)是上呼吸道感染的主要病因,据推测其可引发哮喘恶化。然而,HRV 是否在危象期被检出是因为上呼吸道感染常伴随哮喘发作,还是因为其可特异性引发恶化,尚不清楚。此外,尽管已有若干假说用于解释病毒引发的恶化,但作用机制仍不明确。
明确 HRV 在儿科哮喘恶化中的作用,以及介导喘息的机制。
我们前瞻性研究了 409 例因上呼吸道感染就诊的伴或不伴喘息的哮喘患儿。对比了不同严重程度急性哮喘患儿中与疾病相关的候选病毒和免疫介质。
即使在校正了预先定义的相关人口统计学和临床变量后,HRV 感染与哮喘恶化仍具有特异性关联(比值比,1.90;95%置信区间,1.21-2.99;P=0.005)。感染 HRV 的喘息和非喘息患儿之间,病毒滴度、HRV 种属、炎症或过敏分子并无差异。感染 HRV 的喘息患儿中Ⅲ型干扰素 λ1(IFN-λ1)水平高于非喘息患儿(P<0.001),且与症状恶化程度呈正相关(P<0.001)。此外,在校正 IFN-λ1 后,感染 HRV 的哮喘患儿喘息的可能性不再高于 HRV 阴性患儿(比值比,1.18;95%置信区间,0.57-2.46;P=0.66)。
我们的研究结果提示,哮喘患儿 HRV 感染与急性喘息具有特异性关联,且Ⅲ型 IFN-λ1 反应介导了 HRV 引发的恶化。IFN-λ1 的调节可作为 HRV 引发恶化的治疗靶点进行研究。